Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
Robinson, James E., Hastie, Kathryn M., Cross, Robert W., Yenni, Rachael E., Elliott, Deborah H., Rouelle, Julie A., Kannadka, Chandrika B., Smira, Ashley A., Garry, Courtney E., Bradley, Benjamin T., Yu, Haini, Shaffer, Jeffrey G., Boisen, Matt L., Hartnett, Jessica N., Zandonatti, Michelle A., Rowland, Megan M., Heinrich, Megan L., Martínez-Sobrido, Luis, Cheng, Benson, de la Torre, Juan C., Andersen, Kristian G., Goba, Augustine, Momoh, Mambu, Fullah, Mohamed, Gbakie, Michael, Kanneh, Lansana, Koroma, Veronica J., Fonnie, Richard, Jalloh, Simbirie C., Kargbo, Brima, Vandi, Mohamed A., Gbetuwa, Momoh, Ikponmwosa, Odia, Asogun, Danny A., Okokhere, Peter O., Follarin, Onikepe A., Schieffelin, John S., Pitts, Kelly R., Geisbert, Joan B., Kulakoski, Peter C., Wilson, Russell B., Happi, Christian T., Sabeti, Pardis C., Gevao, Sahr M., Khan, S. Humarr, Grant, Donald S., Geisbert, Thomas W., Saphire, Erica Ollmann, Branco, Luis M., Garry, Robert F.
Published in Nature communications (10.05.2016)
Published in Nature communications (10.05.2016)
Get full text
Journal Article